Industry News
TGA miscounted clinical trial numbers
The Therapeutic Goods Administration has upwardly revised its statistics on Australian clinical trial notifications from 2009-2012, after discovering errors in its earlier reports. [ + ]
Support for research infrastructure renewed
As part of the 2013-14 Budget, the Australian Government has announced additional funding for the renewal of the National Collaborative Research Infrastructure Strategy. [ + ]
Warming oceans impact marine-life habits
Change is afoot in the broader marine landscape as patterns of movement and breeding modes of marine animals adjust to a changing climate. [ + ]
Bacterial bio-insecticide
Australian and New Zealand researchers have discovered a new way in which toxin-producing bacteria store their cytotoxic chemicals. [ + ]
Review to reduce red tape for universities
The Australian Government today released a major review examining how red tape can be reduced for universities while also supporting the quality and excellence of Australia’s world-class university system. [ + ]
Monash develops compact supercapacitors with energy storage similar to conventional batteries
Next-generation energy storage is now a step closer with Monash University researchers developing an engineering first - a graphene-based device that is compact, yet lasts as long as a conventional battery. [ + ]
ResMed FY13 profit grows 21%
ResMed (ASX:RMD) has reported a 21% increase in FY13 net profit, but a decline in profit for the fourth quarter due to its $25m payout to the University of Sydney. [ + ]
Smart aquarium
A new aquarium that simulates the ocean will place Australian marine science at the forefront of marine research and discovery. [ + ]
Avita enrols first patients for leg ulcer trial
Avita Medical (ASX:AVH) has signed up the first patients for a trial of its ReCell Spray on Skin product for the new application of treating venous leg ulcers. [ + ]
Bacteria invest in evolutionary success
Researchers at Sydney and Exeter Universities have, for the first time, recreated and analysed the complex interplay between bacterial investment strategies and their outcomes. [ + ]
Why one person’s mutation kills when the same mutation in someone else is benign
Scientists have begun to understand how the rest of the genome interacts with mutations, explaining why not everyone with identical genetic mutations develops a disease. [ + ]
Rigaku and Emerald Bio announce strategic alliance in protein crystallography
Rigaku, a supplier of X-ray instrumentation and automation equipment for structural biology, has acquired the crystallisation reagent and consumable business, including Wizard screens, from protein science company Emerald Bio. [ + ]
Sea simulator to solve the ocean’s mysteries
Minister for Innovation, Industry, Science and Research Senator Kim Carr and Senator for Queensland Jan McLucas yesterday opened the National Sea Simulator (SeaSim) at the Australian Institute of Marine Science (AIMS) in Townsville. [ + ]
GTG raising up to $10.6m for BREVAGen expansion
Genetic Technologies (ASX:GTG) is conducting a capital raising worth up to $10.6m and will use the funds to expand its US market reach for breast cancer risk test BREVAGen. [ + ]
Supercomputer switched on
Ranked as one of the largest supercomputers in the world, Australia’s fastest supercomputer has been turned on. [ + ]